Versant Capital Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5K | Buy |
1,371
+359
| +35% | +$3.8K | ﹤0.01% | 1698 |
|
|
2025
Q1 | $15.2K | Buy |
1,012
+967
| +2,149% | +$14.5K | ﹤0.01% | 1494 |
|
|
2024
Q4 | $741 | Buy |
45
+35
| +350% | +$576 | ﹤0.01% | 2237 |
|
|
2024
Q3 | $247 | Hold |
10
| – | – | ﹤0.01% | 1946 |
|
|
2024
Q2 | $253 | Hold |
10
| – | – | ﹤0.01% | 1876 |
|
|
2024
Q1 | $254 | Hold |
10
| – | – | ﹤0.01% | 1809 |
|
|
2023
Q4 | $227 | Sell |
10
-96
| -91% | -$2.18K | ﹤0.01% | 1853 |
|
|
2023
Q3 | $1.98K | Sell |
106
-453
| -81% | -$8.44K | ﹤0.01% | 1317 |
|
|
2023
Q2 | $14.5K | Hold |
559
| – | – | ﹤0.01% | 625 |
|
|
2023
Q1 | $16K | Sell |
559
-11
| -2% | -$314 | 0.01% | 573 |
|
|
2022
Q4 | $16.9K | Sell |
570
-60
| -10% | -$1.78K | 0.01% | 513 |
|
|
2022
Q3 | $15K | Buy |
630
+523
| +489% | +$12.5K | 0.01% | 501 |
|
|
2022
Q2 | $2K | Buy |
107
+89
| +494% | +$1.66K | ﹤0.01% | 1060 |
|
|
2022
Q1 | $0 | Buy |
+18
| New | – | ﹤0.01% | 1447 |
|
|
2020
Q1 | – | Sell |
-211
| Closed | -$10K | – | 1294 |
|
|
2019
Q4 | $10K | Hold |
211
| – | – | 0.01% | 685 |
|
|
2019
Q3 | $11K | Buy |
211
+112
| +113% | +$5.84K | 0.01% | 663 |
|
|
2019
Q2 | $4K | Buy |
99
+95
| +2,375% | +$3.84K | ﹤0.01% | 1000 |
|
|
2019
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1546 |
|
|
2018
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1462 |
|
|
2018
Q3 | $0 | Sell |
4
-73
| -95% | – | ﹤0.01% | 1507 |
|
|
2018
Q2 | $2K | Sell |
77
-115
| -60% | -$2.99K | ﹤0.01% | 1274 |
|
|
2018
Q1 | $9K | Sell |
192
-6
| -3% | -$281 | ﹤0.01% | 902 |
|
|
2017
Q4 | $10K | Sell |
198
-20
| -9% | -$1.01K | ﹤0.01% | 902 |
|
|
2017
Q3 | $12K | Buy |
218
+172
| +374% | +$9.47K | 0.01% | 759 |
|
|
2017
Q2 | $2K | Buy |
+46
| New | +$2K | ﹤0.01% | 1223 |
|